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Purpose/Objective: An analytical function which models the 
photon peripheral dose as a function of the distance (along 
the craneo-caudal axis) to the isocenter treatment has been 
developed [1] by our group. This model, which also accounts 
for prescription dose to MU ratio and an effective field size, 
was parameterized using standard 6LiF/7LiF pairs of 
dosimeters TLD600-TLD700 calibrated with a 137Cs calibration 
source at secondary standard dosimetry laboratory in CIEMAT 
(Spain). Those measurements had been carried out on a 
whole-body anthropomorphic phantom [2] irradiated with 
3DCFRT, IMRT and VMAT treatments. The model allows 
peripheral dose estimation for any kind of isocentric 
treatment.  
The purpose of this work was to make a validation of our 
analytical model for photon peripheral dose calculation in 
H&N and prostate IMRT treatments, using an independent 
dosimetry system. 
Materials and Methods: Two, H&N and prostate, 6 MV IMRT 
treatment plans (for which our approximation for an 
effective field size might be less accurate), were chosen. A 
Varian 21EX linac unit was used to deliver one treatment 
fraction, with 0.097 cGy/UM and 0.277 cGy/UM to the 
isocenter for the H&N (9 fields) and prostate (7 fields) cases, 
respectively. TLD-100 pairs (calibrated with a 6 MV beam) of 
dosimeters, were placed inside the phantom outside the 
irradiated volume. As dose calibration factors for the TLDs 
were obtained under standard conditions for a 6 MV linac 
spectra, and the measurements carried out in peripheral 
photon spectra inside a medium, uncertainties in dose 
determination could be around 3-5%. Bigger uncertainties 
should be expected in the very low dose tail of doses. 
Our model was used for calculating the dose/MU at the TLD´s 
positions as if these were have been placed at mid thickness 
of the phantom´s thorax (this is a sensible approximation as 
actual depths for different beams might compensate). 
Results: Bars in the Figure, depict the photon dose rates 
measured with the TLD´s pairs as a function of the distance 
to the isocenter along the craneo-caudal direction (1.a and 
1.b for the H&N and prostate cases, respectively). 
Differences with the model estimations are represented by 
the error lines on the top of each bar. An exponential 
behaviour is obtained, as expected. 
For the H&N irradiations, differences between measurements 
and model predictions ranged from 15.6 µSv/MU to -0.1 
µSv/MU. For the prostate case this range was (2.7-0.2) 
µSv/MU. For both cases, in all points except one of them, the 
model overestimated the TLD´s measurements. 
Figure.  
 
Conclusions: Validation of a photon peripheral dose 
calculation model has been carried out against an 
independent setup and dosimetric system. Good agreement 
has been found between our model and the experimental 
measurements. However, our current modelization of the 
influence of the field size can be improved for the IMRT cases 
as the model consistently overestimates the measurements. 
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Purpose/Objective: Recently the risk of secondary cancer 
after advanced radiation therapy has become an important 
issue, especially stochastic effects induced by low-LET 
exposure away from the treated region. The out-of-field 
measurements are sophisticated because of the complexity of 
radiation components (radiation is scattered many times), 
the unknown energy spectrum and the low level of doses. 
These conditions disqualify many detectors which are 
commonly used in clinical dosimetry. The aim of the work 
was to check the response of available detectors in low doses 
outside the treated area, the discussion of the usefulness of 
dosimetric tools and to determine the out-of-field doses for 
photon therapy. 
Materials and Methods: The measurements were done for 6 
and 20 MV delivered with Varian Clinac2300 linear 
accelerator. The dose distributions were obtained using TL 
detectors (TLD100, TLD600, TLD700 Harshaw), radiochromic 
films (Gafchromic EBT). The detectors were placed in a 
specially designed water phantom (40cmx35cmx90cm) on 
8cm depth (SSD=92cm) in 10x10cm2 open field and the total 
dose delivered to the target was 75 Gy. There were several 
measurement points in which the detectors were placed: in 
isocentre (CAX) and outside the field in distance from 
isocentre: P210 cm; P315 cm; P420 cm; P525 cm; P630 cm; P735 
cm. If necessary, correlation coefficients for energy were 
used. Additional doses were compared to TPS calculations 
(AAA alghoritm). 
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Results: Moving away from the edge of the field caused the 
doses to decrease rapidly. The out-of-field doses of total 
75Gy for the target were estimated (in P2 and P7 respectively) 
to be around: for 20MV - TLD 100: <3% and <1%; TLD 600: <3% 
and <2%; TLD 700: <2% and <0.2%; Gafchromic: <2% and 
<0.01%; for 6MV - TLD 100:<3.5 % and <0.15%; Gafchromic: 
<2.5% and <0.03% (Table 1 and Graph 1) . Our results show 
that in the close-to-field area the dose level could reach 
even 1.5Gy. Doses delivered to organs located far from the 
treatment volume could be about several cGy. 
 
 
 
 
 
Conclusions: There is a very good agreement between doses 
measured with TLD700, TPS (close to the edge of the field) 
and Gafchromic films. However, the treatment planning 
systems do not give enough information about the dose and 
energy spectrum far away from irradiation field. What is 
more, the applied methods do not take into account neutron 
components except for TLD 100 and 600 where the measured 
signals were enlarged because of the neutron irradiation. 
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Purpose/Objective: During radiation therapy, patients 
receive undesired dose from neutrons produced in collimators 
or in the patient. The neutron dose is mainly associated with 
a potentially increased risk of radiation induced cancer. 
Measurements of neutron doses are not trivial, and often rely 
on passive detectors or detectors of large physical size, 
unsuited for in-phantom measurements. A neutron detector 
based on radiation effects in SRAM (Static Random Access 
Memory) memories has been developed at the University of 
Bergen for applications in particle therapy. Characterizations 
of several different SRAM memories were performed at 
European irradiation facilities at different particle energies. 
The motivation for the project was the prospect of having an 
active and compact neutron detector which also would be 
insensitive to photons.  
Materials and Methods: The detector operates by counting 
single event upsets (SEU); non-permanent errors induced by 
high energy particles traversing the detector. The readout of 
the memories is handled by a Field Programmable Gate Array 
(FPGA) which collects and stores the number of SEU counts 
locally for each SRAM. The detectors are interfaced over a 
serial bus with a computer which records and logs the SEU 
count for each detector at regular intervals. SEU cross-
sections of selected SRAM memories were measured in 
neutron beams at PTB (Physikalische Technische 
Bundesanstalt) and at TSL (The Svedberg Laboratory), in a 
mixed hadron field at the CERF facility (the CERN-EU high-
energy Reference Field), in a proton beam at the OCL (Oslo 
Cyclotron Laboratory), and in a thermal neutron field at the 
Jeep II research reactor at the Institute for Energy 
Technology (IFE). 
Results: Based on the outcome of irradiation tests at CERF 
and OCL a 16 Mbit SRAM memory from the vendor Cypress 
was found to be the most promising candidate. The 
combination of a relatively high SEU cross section and stable 
behavior during measurements, including linear response, 
were the arguments for the choice of SRAM memory for the 
final detector. The results for the final detector are 
summarized in Figure 1.  
 
 
